Rong Deng

Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data

Rong Deng, Suhasini Iyer, Frank‐Peter Theil et al. · mAbs · 2011 · 283 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

A strategy for risk mitigation of antibodies with fast clearance

Isidro Hötzel, Frank‐Peter Theil, L. Bernstein et al. · mAbs · 2012 · 247 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Prevalence and associated factors of depression and anxiety among nurses during the outbreak of COVID-19 in China: A cross-sectional study

Rujun Zheng, Yuhong Zhou, Yan Fu et al. · International Journal of Nursing Studies · 2020 · 206 citations · Full text

Nursing, Mental Health Nursing, Psychiatry +10

Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor

Rong Deng, Daniela Bumbaca, Cinthia V. Pastuskovas et al. · mAbs · 2016 · 201 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge

Bing Li, Devin B. Tesar, C. Andrew Boswell et al. · mAbs · 2014 · 122 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15